Product Program year 2025 Source: CMS Open Payments

Amo Phaco Needle

Device Optics

PDI 05050474521117

Open in the dashboard

General payments

$103,661

536 payments

Research payments

$0

0 payments

Through program year 2025, $103,661 in general payments and $0 in research payments were reported against Amo Phaco Needle (Optics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $15,428 113
2024 General $34,855 136
2023 General $10,983 90
2022 General $16,479 89
2021 General $25,916 108

Breakdown

Who paid General payments · program years 2021–2025
  1. Johnson & Johnson Surgical Vision, Inc. $103,495 533 payments
  2. Johnson & Johnson Vision Care, Inc. $134 2 payments
  3. Actelion Pharmaceuticals US, Inc. $32 1 payment
Top recipients General payments · program year 2025
  1. Steven Dewey Ophthalmology · Colorado Springs, CO $6,231 40% · 2 payments
  2. Tal Raviv Ophthalmology · New York, NY $4,887 32% · 3 payments
  3. Mark Cheung Optometrist · Bakersfield, CA $232 2% · 3 payments
  4. David Hamilton Ophthalmology · Los Angeles, CA $195 1% · 1 payment
  5. Jay Schwartz Ophthalmology · Scottsdale, AZ $176 1% · 8 payments

The top 5 of 86 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Ophthalmology $13,717 89% · 54 practitioners
  2. Optometrist $946 6% · 19 practitioners
  3. Anesthesiology $217 1% · 2 practitioners
  4. Cornea and External Diseases Specialist Ophthalmology $163 1% · 4 practitioners
  5. Glaucoma Specialist Ophthalmology $135 <1% · 2 practitioners

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Colorado $6,231 40% · 1 recipient
  2. New York $5,040 33% · 8 recipients
  3. California $1,716 11% · 27 recipients
  4. Arizona $444 3% · 7 recipients
  5. Oregon $280 2% · 7 recipients

The top 5 of 20 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

536 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record